These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31820289)

  • 1. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder.
    Li MJ; Briones MS; Heinzerling KG; Kalmin MM; Shoptaw SJ
    Drug Alcohol Depend; 2020 Jan; 206():107776. PubMed ID: 31812878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.
    Worley MJ; Swanson A-N; Heinzerling KG; Roche DJ; Shoptaw S
    Drug Alcohol Depend; 2016 May; 162():245-50. PubMed ID: 26993372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
    Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment.
    DeYoung DZ; Heinzerling KG; Swanson AN; Tsuang J; Furst BA; Yi Y; Wu YN; Moody DE; Andrenyak DM; Shoptaw SJ
    J Clin Psychopharmacol; 2016 Aug; 36(4):347-54. PubMed ID: 27269956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.
    Ray LA; Bujarski S; Shoptaw S; Roche DJ; Heinzerling K; Miotto K
    Neuropsychopharmacology; 2017 Aug; 42(9):1776-1788. PubMed ID: 28091532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial.
    Briones M; Shoptaw S; Cook R; Worley M; Swanson AN; Moody DE; Fang WB; Tsuang J; Furst B; Heinzerling K
    Drug Alcohol Depend; 2018 Aug; 189():30-36. PubMed ID: 29860057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.
    Shoptaw S; Heinzerling KG; Rotheram-Fuller E; Steward T; Wang J; Swanson AN; De La Garza R; Newton T; Ling W
    Drug Alcohol Depend; 2008 Aug; 96(3):222-32. PubMed ID: 18468815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.
    Ling W; Chang L; Hillhouse M; Ang A; Striebel J; Jenkins J; Hernandez J; Olaer M; Mooney L; Reed S; Fukaya E; Kogachi S; Alicata D; Holmes N; Esagoff A
    Addiction; 2014 Sep; 109(9):1489-500. PubMed ID: 24825486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
    Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
    Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
    Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder.
    Cummings JR; Tomiyama AJ; Ray LA
    J Addict Med; 2018; 12(5):410-417. PubMed ID: 29794557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirtazapine to reduce methamphetamine use: a randomized controlled trial.
    Colfax GN; Santos GM; Das M; Santos DM; Matheson T; Gasper J; Shoptaw S; Vittinghoff E
    Arch Gen Psychiatry; 2011 Nov; 68(11):1168-75. PubMed ID: 22065532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety.
    Johnson JL; Kwok YH; Sumracki NM; Swift JE; Hutchinson MR; Johnson K; Williams DB; Tuke J; Rolan PE
    Headache; 2015 Oct; 55(9):1192-208. PubMed ID: 26367865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.
    McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BT; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M
    Trials; 2024 Jun; 25(1):408. PubMed ID: 38907288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil for the treatment of methamphetamine dependence.
    Anderson AL; Li SH; Biswas K; McSherry F; Holmes T; Iturriaga E; Kahn R; Chiang N; Beresford T; Campbell J; Haning W; Mawhinney J; McCann M; Rawson R; Stock C; Weis D; Yu E; Elkashef AM
    Drug Alcohol Depend; 2012 Jan; 120(1-3):135-41. PubMed ID: 21840138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.